-

BTIG Adds Andrew Jarman to Fixed Income Credit Team in London

LONDON--(BUSINESS WIRE)--BTIG Limited announced today that Andrew Jarman has joined the firm’s Fixed Income Credit sales and trading team as a Managing Director. Mr. Jarman will enhance our existing credit business that provides quality liquidity solutions for our global customer base.

“We are excited to have Andrew join our team,” said Christopher Rollins, Chief Executive Officer of BTIG Limited in London. “He has a diverse knowledge base and deep understanding of the fixed income marketplace, traditional and alternative investment strategies as well as strong relationships with portfolio managers that will broaden our network and credit capabilities to strategically grow our offering across EMEA.”

Mr. Jarman brings more than 20 years of experience to the firm. Prior to BTIG, he was a Founder and Managing Director at Sigered Financial Markets. Previously, Mr. Jarman was Co-Head of Leveraged and Distressed Credit at GFI Securities and a Director within European High Yield Credit Trading at Citibank. Earlier in his career, he was a Director within Hedge Fund Sales as well as Head of European High Yield Credit Trading at Deutsche Bank.

BTIG’s global fixed income credit platform focuses on sales, trading, sourcing and strategy for a wide range of credit products including bonds, leveraged loans, trade claims, reorg. equity, special situations and high-yield, distressed, convertible and private securities.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 725 employees, BTIG, LLC and its affiliates operate out of 22 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.

Contacts

Media:
Jill Gordon
443.668.2055
jgordon@prosek.com

Ariana Crupi
212.738.6142
acrupi@btig.com

BTIG


Release Versions

Contacts

Media:
Jill Gordon
443.668.2055
jgordon@prosek.com

Ariana Crupi
212.738.6142
acrupi@btig.com

More News From BTIG

BTIG Expands Consumer Staples Research Coverage with the Addition of Owen Bennett

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Owen Bennett has joined the firm as Managing Director and Consumer Staples Analyst, focusing on the tobacco and beverage sectors. "We are thrilled to welcome Owen to BTIG. His extensive expertise in the tobacco space, coupled with deep industry relationships and a differentiated research approach, will enhance our consumer sector coverage and broaden the insights we offer to clients," said Ryan Serwin, CFA, BTIG's Director of Research. "Owen’...

BTIG Announces Strategic Hire for TMT Investment Banking

NEW YORK--(BUSINESS WIRE)--BTIG announced today that Sasson Darwish has joined the firm as a Managing Director and Co-Head of TMT Investment Banking, alongside Brett Fodero and Steven Marder. This hire underscores BTIG’s long-term commitment to growing its Investment Banking practice—particularly within TMT—while continuing to deliver innovative advisory and capital markets solutions to clients. Mr. Darwish brings more than 25 years of investment banking and corporate leadership experience to B...

BTIG to Host 5th Annual Ophthalmology Day on December 1, 2025

NEW YORK--(BUSINESS WIRE)--BTIG announced today that its 5th Annual Ophthalmology Day will take place on Monday, December 1, 2025. The virtual, one-day event will include thematic panel discussions and one-on-one meetings. The event will be hosted by: Ryan Zimmerman, BTIG Medical Technology Analyst Julian Harrison, BTIG Biotechnology Analyst Thomas Shrader, PhD, CFA, BTIG Biotechnology Analyst Justin Zelin, BTIG Biotechnology Analyst Jeet Mukherjee, BTIG Biotechnology Analyst “We are proud to c...
Back to Newsroom